Fosamprenavir or atazanavir once daily boosted with ritonavir 100mg, plus tenofovir/emtricitabine, for the initial treatment of HIV infection: 48-week results of ALERT
Authors:
- Kimberly Y SmithKSKimberly Y Smith
- Winkler G WeinbergWWWinkler G Weinberg
- Edwin DeJesusEDEdwin DeJesus
- Margaret A FischlMFMargaret A Fischl
- Qiming LiaoQLQiming Liao
- Lisa L RossLRLisa L Ross
- Gary E PakesGPGary E Pakes
- Keith A PappaKPKeith A Pappa
- C Tracey PakesCPC Tracey Pakes
- C Tracey LancasterCLC Tracey Lancaster
Open Access
- 1 January 2008
- journal article
- Published by Springer Nature in AIDS Research and Therapy
- Vol. 5 (1) , 5
Abstract
Once-daily (QD) ritonavir 100 mg-boosted fosamprenavir 1400 mg (FPV/r100) or atazanavir 300 mg (ATV/r100), plus tenofovir/emtricitabine (TDF/FTC) 300 mg/200 mg, have not been compared as initial antiretroviral treatment. To address this data gap, we conducted an open-label, multicenter 48-week study (ALERT) in 106 antiretroviral-naïve, HIV-infected patients (median HIV-1 RNA 4.9 log10 copies/mL; CD4+ count 191 cells/mm3) randomly assigned to the FPV/r100 or ATV/r100 regimens.Keywords
This publication has 20 references indexed in Scilit:
- Tenofovir-Associated Fanconi Syndrome: Review of the FDA Adverse Event Reporting SystemAIDS Patient Care and STDs, 2008
- Greater Tenofovir‐Associated Renal Function Decline with Protease Inhibitor–Based versus Nonnucleoside Reverse‐Transcriptase Inhibitor–Based TherapyThe Journal of Infectious Diseases, 2008
- British HIV Association (BHIVA) guidelines for the treatment of HIV‐infected adults with antiretroviral therapy (2006)HIV Medicine, 2006
- Treatment for Adult HIV InfectionJAMA, 2006
- Pharmacokinetics of Tenofovir Disoproxil Fumarate and Ritonavir-Boosted Saquinavir Mesylate Administered Alone or in Combination at Steady StateAntimicrobial Agents and Chemotherapy, 2006
- Lack of Pharmacokinetic Drug Interaction between Tenofovir Disoproxil Fumarate and Nelfinavir MesylateAntimicrobial Agents and Chemotherapy, 2005
- AtazanavirAnnals of Pharmacotherapy, 2004
- Comparison of Once-Daily Atazanavir With Efavirenz, Each in Combination With Fixed-Dose Zidovudine and Lamivudine, As Initial Therapy for Patients Infected With HIVJAIDS Journal of Acquired Immune Deficiency Syndromes, 2004
- A Review of Low-Dose Ritonavir in Protease Inhibitor Combination TherapyClinical Infectious Diseases, 2003
- The effect of ritonavir on saquinavir plasma concentration is independent of ritonavir dosage: combined analysis of pharmacokinetic data from 97 subjectsHIV Medicine, 2002